# Lenalidomide

NDC: 0378-1935
Generic name: Lenalidomide
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20220906

FDA application: ANDA213912

## Active ingredients

- LENALIDOMIDE: 2.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-1935"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-1935
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=76f6c1e7-985b-43d9-892c-849df50ae80e